丁新敏①, 陈秀丽②, 王平②. Rad51C 在DNA 损伤修复中的研究进展*[J]. 中国肿瘤临床, 2016, 43(18): 830-833. DOI: 10.3969/j.issn.1000-8179.2016.18.502
引用本文: 丁新敏①, 陈秀丽②, 王平②. Rad51C 在DNA 损伤修复中的研究进展*[J]. 中国肿瘤临床, 2016, 43(18): 830-833. DOI: 10.3969/j.issn.1000-8179.2016.18.502
Xinmin DING1, Xiuli CHEN2, Ping WANG2. Research progress on Rad51C in DNA damage repair[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(18): 830-833. DOI: 10.3969/j.issn.1000-8179.2016.18.502
Citation: Xinmin DING1, Xiuli CHEN2, Ping WANG2. Research progress on Rad51C in DNA damage repair[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 43(18): 830-833. DOI: 10.3969/j.issn.1000-8179.2016.18.502

Rad51C 在DNA 损伤修复中的研究进展*

Research progress on Rad51C in DNA damage repair

  • 摘要: 细胞毒性物质及电离辐射等易致细胞DNA 损伤,真核生物中DNA 双链断裂(double strand breaks,DSBs)修复的主要通路是同源重组(homologous recombination,HR)。 Rad51C 蛋白作为HR通路的关键因子,其表达异常可致DNA 损伤修复的失调,引起基因组的不稳定,最终导致肿瘤的发生发展。近年来随着对Rad51C 基因的研究,发现Rad51C 可能会成为恶性肿瘤治疗的潜在靶点。本文就Rad51C 在DNA 损伤修复及放疗中作用的研究进展进行综述。

     

    Abstract: Cytotoxic substances and ionizing radiation can easily induce DNA damage, and double strand breaks (DSBs) are the main form of DNA damage. DNA damage can activate intracellular DNA damage responses and further induce related biological effects, such as DNA damage repair and cell cycle arrest. Homologous recombination (HR) is the primary DSB repair mechanism in eukaryotes. Abnormal expression of Rad 51C, which is a key factor in the HR pathway, may result in DNA repair disorder, genomic instability, and eventually lead to tumor formation. In recent studies, researchers considered Rad 51C as a potential target for cancer treatment. We reviewed the research progress on Rad 51C in DNA damage repair and radiotherapy.

     

/

返回文章
返回